|
Cancer News |
|
|
Archives 2008 | 2007 | 2006 | 2005 | 2004 |
|
|
|
| Oct 23, 2009 |
U.Va. Researchers Develop Breakthrough Method That Could Eliminate Trial-and-Error Aspect of Many Cancer Treatments Many cancer patients must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the U.Va. Health System have developed a breakthrough method that could one day eliminate this trial-and-error approach to treating many cancers. |
|
|
|
| Oct 23, 2009 |
U.Va. Biomedical Engineer Receives Packard Fellowship in Science and Engineering Kevin Janes, an assistant professor of biomedical engineering at the University of Virginia, is among 16 promising scientific researchers from around the United States who will each receive an unrestricted research grant of $875,000 over five years. His research focuses on understanding how signaling networks function within cells, which has important implications for diseases such as cancer. |
|
|
|
| Oct 16, 2009 |
Casteen and Parsons Receive Thomas Jefferson Awards The University of Virginia presented two Thomas Jefferson Awards today, one recognizing excellence in service and the other recognizing excellence in scholarship. They are the highest honors that the University bestows. The award for scholarship went to J. Thomas Parsons, chairman of the Department of Microbiology and F. Palmer Weber Professor of Medical Research. |
|
|
|
| Oct 4, 2009 |
Firm's Drug Could be a Brain Cancer Breakthrough Tau Therapeutics, a start-up company with ties to the University of Virginia, has developed a drug treatment it believes will stop the growth of cancer cells. |
|
|
|
| Sept 25, 2009 |
NIH Names Kevin Janes a 'New Innovator' Kevin Janes, an assistant professor of biomedical engineering at the University of Virginia, is one of 55 engineers and scientists from around the country to receive a 2009 National Institutes of Health "New Innovator Award." |
|
|
|
| Aug 12, 2009 |
U.Va. Researcher Aims to Make Cancer Manageable Until recently, treatment for cancer - though quite sophisticated in practice - has been limited to three basic approaches: killing cancer cells by removing them surgically, blasting them with radiation or poisoning them with chemotherapy. |
|
|
|
| Aug 10, 2009 |
New Light-Emitting Biomaterial Could Improve Tumor Imaging, Study Shows A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. |
|
|
|
| Jul 16, 2009 |
U.S. News Honors U.Va. Health System Specialties Three medical specialties at the University of Virginia Health System are ranked in the 20th annual survey of "America's Best Hospitals" from U.S. News & World Report. U.Va. specialties ranked in this year's guide are endocrinology (12th); cancer (39th); and ear, nose and throat (47th). |
|
|
|
| Jun 16, 2009 |
Carter-Harrison Research Building Will Boost U.Va.'s Biomedicine Research The University of Virginia has opened its new, 102,000-square-foot Carter-Harrison Research Building, which will house nearly 240 scientists and lab personnel comprising an estimated 60 research teams. |
|
|
|
| Jun 16, 2009 |
University of Virginia Health System Scientists Find Faster, Cheaper Way To Investigate How Particular Genes Suppress or Cause Cancer Researchers at the University of Virginia Health System have found a new way to study how genes function in living organisms, and their approach could substantially cut the time and costs that drug makers spend in searching for potential targets for new cancer therapies. |
|
|
|
| May 14, 2009 |
U.Va. Health System Study Shows Early Success in Combining Two Emerging Medical Technologies to Treat Deadly Brain Tumors New research from the University of Virginia Health System shows that, when combined, two emerging medical technologies hold significant promise for treating the most deadly and devastating form of brain tumor, glioblastoma multiforme, or GBM. |
|
|
|
| May 7, 2009 |
Brain Cancer Clinical Trials Conducted at U.Va. Health System Lead to Accelerated Approval of Medication Dr. David Schiff and colleagues at the University of Virginia Cancer Center were key researchers in a large national clinical trial that has resulted in the U.S. Food and Drug Administration's accelerated approval of the medication bevacizumab, or Avastin, to treat the recurrence of glioblastoma. |
|
|
|
| Apr 7, 2009 |
National Guide Names 47 U.Va. Doctors Top in Their Fields Forty-seven physicians from the University of Virginia Health System were included in the eighth edition of "America's Top Doctors." Published annually by Castle Connolly Medical Ltd., the guide recognizes physicians who are considered among the top 1 percent in the nation in their medical specialties and sub-specialties. |
|
|
|
| Mar 29, 2009 |
New U.Va. Discovery Raises Doubts About Use of Certain Targeted Therapies in Bladder Cancer Researchers at the University of Virginia Health System have found that one of the genes commonly thought to promote the growth and spread of some types of cancers is in fact beneficial in bladder cancer - a major discovery that could significantly alter the way bladder cancers are treated in the future. |
|
|
|
| Feb 26, 2009 |
Documentary Sheds Light on Living with the Knowledge of Predisposition to Breast and Ovarian Cancer A documentary film about predicting breast and ovarian cancer and the consequences of knowing you are at risk, "In the Family," will be screened March 25 at 7 p.m. in Minor Hall Room 125 at the University of Virginia. |
|
|
|
| Feb 2, 2009 |
Cancer Society's Health Forum for Black Men Set Feb. 7 The American Cancer Society will host its third annual "African American Men's Health Forum" from 8 a.m. to 2 p.m. Feb. 7 at the Greater Richmond Convention Center, 403 N. Third St. |
|
|
|
| Jan 22, 2009 |
U.Va. Medical Researcher Receives $1.2 Million Grant to Develop Pancreatic Cancer Screening Pancreatic cancer is the fourth-highest cancer killer in the United States. The cancer has one of the highest fatality rates, with more than 37,000 diagnoses and nearly 34,000 deaths in 2007, according to Kimberly Kelly, assistant professor of biomedical engineering at the University of Virginia School of Medicine. |
|
|
|